ASTRO: Intensity-Modulated RT, Proton Beam Therapy Have Similar Outcomes in Prostate Cancer

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 4, 2024.

By Lori Solomon HealthDay Reporter

FRIDAY, Oct. 4, 2024 -- Intensity-modulated radiation therapy (IMRT) and proton beam therapy (PBT) offer similar outcomes for patients with localized prostate cancer, according to a study presented at the annual meeting of the American Society for Radiation Oncology, held from Sept. 29 to Oct. 2 in Washington, D.C.

Jason A. Efstathiou, M.D., from Massachusetts General Hospital in Boston, and colleagues randomly assigned 450 patients with intermediate- or low-risk prostate cancer and without hormonal therapy to PBT or IMRT. Participants were followed longitudinally to assess patient-reported outcomes of bowel, urinary, and sexual function for 60 months after completion of radiotherapy.

The researchers observed no difference between PBT or IMRT for mean change in bowel function score at 24 months, with both arms showing only small, clinically nonmeaningful declines from baseline. There also was no difference seen in bowel function at earlier time points (three to 18 months) or later time points (36 to 60 months). At all time points, there were no differences observed in urinary, sexual, or hormonal domains. Progression-free survival (PFS) was also similar between the groups (93.4 versus 93.7 percent at 60 months; hazard ratio, 1.16; 95 percent confidence interval, 0.53 to 2.57; P = 0.706). When stratifying across low-versus intermediate-risk disease, age, use of rectal spacer, and fractionation schedule, there was no sustained difference observed in any quality-of-life domain or PFS between arms.

"We can use either of these tools with comparably excellent outcomes," Efstathiou said in a statement. "There have been so many advances in the delivery of contemporary radiation -- such as the incorporation of scanned and modulated beams and in-room imaging -- that I think the potential gaps between these technologies have narrowed over time."

Several authors disclosed ties to the pharmaceutical industry.

Press Release

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-05 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords